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Summary
We report the case of a 76-year-old man who had a 
dual-chamber pacemaker implanted 17 years before 
and was initially admitted due to a Campylobacter fe-
tus bacteraemia without any evident source of infec-
tion. He was treated by imipenem/cilastatin followed 
by ciprofloxacin for a total of four weeks. Two months 
later he presented with high fever, night sweats and a 
weight loss of 11 kg. Blood cultures showed the pres-
ence of Campylobacter fetus. An echocardiogram dem-
onstrated vegetations on the pacemaker probes, not 
visualised on the ultrasound performed two months be-
fore. After extraction of the leads and pacemaker and 
another four weeks of intravenous antibiotherapy (imi-
penem/cilastatin and gentamicin), a new system was 
implanted. The patient regained weight and did not 
show any recurrence of symptoms at one-year follow-
up.
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Case report
This 76-year-old man had a dual-chamber pacemaker 
implanted in a right pectoral position 17 years before 
because of a sick sinus syndrome, a right bundle 
branch block and a left anterior fascicular block, with-
out syncope. The battery was changed after 12 years. 
Other medical problems included chronic stable cor-
onary artery disease, high blood pressure, dyslipid-
aemia, well-controlled type II diabetes mellitus (HbA1c 
6%) and chronic renal disease stage IIIa. 
The patient initially presented with a ten-day his-
tory of high fever and night sweats, as well as a three-
day history of lumbar back pain. Clinical examination 
was non-contributive. Laboratory exams showed a 
white blood cell count of 9.2 G/l with 22% non-seg-
mented neutrophils, CRP 104 mg/l and sedimentation 
rate 20 mm/h. Campylobacter fetus grew in three of six 
blood culture bottles. The urine culture was sterile. 
Search for an infection site in-
cluded spinal X-rays followed by a 
lumbar CT-scan which disclosed 
important bone remodelling of the 
L2/L3, L3/L4, L4/L5 intersomatic 
spaces with numerous erosions of 
the vertebral bodies and subchon-
dral condensations without any sign of intradiscal air. 
Although the nature of the bone lesions was not typi-
cally infectious, spondylodiscitis could not be formally 
excluded. Other radiological examinations included a 
chest X-ray and an abdominal CT-scan. Neither showed 
any sign of  infection. A transthoracic echocardiogram 
was performed: there were no alterations suspicious of 
a vegetation, neither on the tricuspid valve nor on the 
pacemaker leads. The left ventricular ejection fraction 
was 60%.
Once Campylobacter fetus was isolated in the blood 
cultures, antibiotherapy by amoxicillin / clavulanic 
acid and clarithromycin was initiated but stopped the 
next day due to a skin reaction. The patient then re-
ceived two days of gentamicin and imipenem/cilastatin 
(500 mg 4 times a day), followed by two weeks of imipe-
nem/cilastatin alone and another two weeks of oral cip-
rofloxacin. The antibiogram showed sensitivity to these 
antibiotics. Shortly after the start of the therapy, the 
 fever disappeared and a pair of blood cultures on the 
eighth day post admission was negative. Laboratory 
 results then showed a white blood cell count of 5 G/l 
with 0% non-segmented neutrophils.
 Because of the reappearance of fever, night sweats 
and a weight loss of 11 kg since the first symptoms, the 
patient was referred to our hospital by his general 
practitioner, two months later. Clinical examination 
was non-contributive. Four out of four blood cultures 
grew Campylobacter fetus. A thoraco-abdominal CT-
scan was repeated. No infection focus could be seen and 
the L2/L3, L3/L4, L4/L5 lesions had not changed. The 
lack of evolution in two months allowed us to rule out 
spondylodiscitis. A transthoracic echocardiogram was 
repeated. This time, the presence of vegetations on the 
pacemaker probes was suspected, motivating a trans-
oesophageal echocardiogram. The latter showed an im-
age suggestive of vegetations on the leads in the right 
atrium and possibly in the right ventricle too.
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longed fever without one’s being able to demonstrate a 
source of infection. However, when the patient pre-
sented two months later, both the transthoracic and 
transoesophageal echocardiograms showed the pres-
ence of vegetations. The growth of Campylobacter fetus 
on the ventricular lead confirmed that this bacteria 
was responsible for the pacemaker infection. Since 
Campylobacter fetus appears to have a tropism for 
 endovascular tissue, we suggest that a transoesopha-
geal echocardiogram be performed systematically in 
patients with a pacemaker and a Campylobacter fetus 
infection, because transoesophageal echocardiography 
allows better visualisation of cardiac valves and pace-
maker leads. We also suggest that prolonged intra-
venous antibiotherapy be administered in patients 
with Campylobacter fetus and a cardiac device, even if 
no vegetations are visible. 
Due to the presence of infected foreign material, 
the optimal treatment is long term antibiotherapy and 
removal of the infected device [1]. Removal of the leads 
can be complicated by cardiac perforation or tears in 
the superior vena cava leading to potentially life-
threatening situations, thus remaining a medical chal-
lenge. 
Campylobacter fetus is an uncommon pathogen. Its 
reservoir hosts are mainly cattle and sheep, and con-
sumption of meat is probably the main source of infec-
A therapy of imipenem/cilastatin and gentamicin 
was initiated. Five days later a transitory pacemaker 
was implanted. The next day the original pacemaker 
was removed and the leads extracted. The pacemaker, 
including the battery and leads, was entirely sur-
rounded by a calcified granulation tissue (fig. 1). The 
ventricular lead grew Campylobacter fetus, whereas 
there was no growth on the atrial lead. Two weeks 
after the start of antibiotherapy, a new dual-chamber 
pacemaker was implanted in a left pectoral position. 
A trans thoracic echocardiogram performed five days 
 after this implantation did not show any vegetations 
and repeated blood cultures were negative. The intra-
venous antibiotherapy was stopped after four weeks 
without any recurrence of infectious symptoms at one-
year follow-up.
Discussion
Despite the absence of previous gastrointestinal symp-
toms, our patient presented with a fever of unknown 
origin finally attributed to a systemic Campylobacter 
fetus infection. We did not perform a transoesophageal 
echocardiogram because symptoms rapidly disap-
peared with the start of antibiotherapy and no vegeta-
tions were seen on the first transthoracic cardiac ultra-
sound. Moreover, Campylobacter fetus can cause pro-
Figure 1
Photograph of the pacemaker during removal. The battery is  completely surrounded by calcified granulation tissue. 
Culture grew Campylobacter fetus.
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tion in humans. Unlike Campylobacter fetus which is 
much more frequent in humans, Campylobacter fetus 
has the capacity to cross the gastrointestinal barrier. 
The presence of a capsule-like S protein prevents com-
plement-mediated killing in the serum, thus causing 
systemic infections. It produces diarrheal illness less 
frequently than Campylobacter jejuni and often occurs 
in immunocompromised patients. C. jejuni infected pa-
tients usually present with fever without any localised 
source of infection. Indeed, Campylobacter fetus has a 
tropism for endovascular tissue but focal infection such 
as meningoencephalitis, osteomyelitis, perimyocardi-
tis, salpingitis or cholecystitis can also occur [2, 3].
To the best of our knowledge, this case is the first 
report of a pacemaker lead infection by C. fetus. A sin-
gle case report of a Campylobacter fetus infection of a 
pacemaker pocket has been published [4]. Interest-
ingly, the patient was immunocompromised and did 
not have any gastrointestinal symptoms nor close con-
tact with animals or undercooked animal products. A 
red swelling developed in the region of the pacemaker 
pocket concomitantly with the worsening of the pa-
tient’s condition. Campylobacter fetus was found in 
three blood cultures and on the extracted pacemaker. 
Transoesophageal echocardiography was normal. Once 
the pacemaker was removed and the pocket drained, 
the patient showed an immediate disappearance of 
symptoms.
Pacemaker lead infections by any pathogen are 
more unusual than pocket infections and more difficult 
to diagnose because they are not always accompanied 
by local symptoms such as erythema or pain at the site 
of implantation. Clinicians should be aware of the pos-
sibility of pacemaker leads infection in every patient 
with a pacemaker and a prolonged febrile illness. Pace-
maker removal and lead extraction are generally indi-
cated together with a prolonged course of antimicrobial 
therapy.
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